58812 Federal Register / Vol. 76, No. 184 / Thursday, September 22, 2011 / Notices 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than October 17, 

2011. 

A. Federal Reserve Bank of 

Philadelphia (William Lang, Senior Vice 

President) 100 North 6th Street, 

Philadelphia, Pennsylvania 19105– 

1521: 

1. Polonia MHC, Huntingdon Valley, 

Pennsylvania; to convert to stock form 

and merge with Polonia Bancorp, Inc., 

Baltimore, Maryland, which proposes to 

become a savings and loan holding 

company by acquiring Polonia Bank, 

Huntingdon Valley, Pennsylvania. 

In connection with this application, 

Polonia Bancorp, Inc., has applied to 

become a bank holding company. 

B. Federal Reserve Bank of Cleveland 

(Nadine Wallman, Vice President) 1455 

East Sixth Street, Cleveland, Ohio 

44101–2566: 

1. Cheviot Mutual Company, Cheviot, 

Ohio; to convert to stock form and 

acquire Cheviot Savings Bank, Cheviot, 

Ohio. Pursuant to the conversion, 

Cheviot, Mutual Holding Company and 

Cheviot Financial Corp., the existing 

federal mid-tier corporation, will cease 

to exist, and Cheviot Savings Bank will 

become a wholly owned subsidiary of 

Cheviot Financial Corp., Cheviot, Ohio, 

a Maryland corporation. 

In addition, Cheviot Financial Corp., 

the Maryland corporation, has applied 

to acquire Cheviot Savings Bank. 

Board of Governors of the Federal Reserve 

System, September 19, 2011. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2011–24388 Filed 9–21–11; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in 

Permissible Nonbanking Activities or 

To Acquire Companies That Are 

Engaged in Permissible Nonbanking 

Activities 

The companies listed in this notice 

have given notice under the Home 

Owners’ Loan Act (HOLA) (12 U.S.C. 

1461 et seq.), and Regulation LL (12 CFR 

part 238) or Regulation MM (12 CFR 

part 239) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is described in §§ 238.53 or 238.54 

of Regulation LL (12 CFR 238.53 or 

238.54) or § 239.8 of Regulation MM (12 

CFR 239.8). Unless otherwise noted, 

these activities will be conducted 

throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 

10a(c)(4)(B) of HOLA (12.U.S.C. 

1467a(c)(4)(B)). 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than October 7, 2011. 

A. Federal Reserve Bank of Dallas (E. 

Ann Worthy, Vice President) 2200 

North Pearl Street, Dallas, Texas 75201– 

2272: 

1. AF Mutual Holding Company, and 

Alamogordo Financial Corp, both of 

Alamogordo, New Mexico; to engage de 

novo through Bank’34, Alamogordo, 

New Mexico, in acquiring and holding 

foreclosed property, nonperforming 

assets, and/or substandard assets 

currently held by Bank ’34, pursuant to 

section 238.54 of Regulation MM. 

Board of Governors of the Federal Reserve 

System, September 19, 2011. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2011–24387 Filed 9–21–11; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: Delisting 

for Cause of Patient Safety 

Organization One, Inc. 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of Delisting. 

SUMMARY: Patient Safety Organization 

One, Inc.: AHRQ has delisted Patient 

Safety Organization One, Inc. as a 

Patient Safety Organization (PSO) 

pursuant to 42 CFR 3.108(b). The 

Patient Safety and Quality Improvement 

Act of 2005 (Patient Safety Act), Pub. L. 

109–41, 42 U.S.C. 299b–21—b–26, 

provides for the formation of PSOs, 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 

delivery. The Patient Safety and Quality 

Improvement Final Rule (Patient Safety 

Rule), 42 CFR part authorizes AHRQ, on 

behalf of the Secretary of HHS, to list as 

a PSO an entity that attests that it meets 

the statutory and regulatory 

requirements for listing. 

A PSO can be ‘‘delisted’’ by the 

Secretary if it is found to no longer meet 

the requirements of the Patient Safety 

Act and Patient Safety Rule. 

DATES: The delisting was effective at 12 

Midnight ET (2400) on July 5, 2011. 

ADDRESSES: The directories of both 

listed and delisted PSOs can be 

accessed electronically at the following 

HHS Web site: http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Diane Cousins, RPh., Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; E-mail: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. HHS issued the Patient Safety 

Rule to implement the Patient Safety 

Act. AHRQ administers the provisions 

of the Patient Safety Act and Patient 

Safety Rule (PDF file, 450 KB. PDF 

Help) relating to the listing and 

operation of PSOs. Section 3.108(d) of 

the Patient Safety Rule requires AHRQ 

to provide public notice when it 

removes an organization from the list of 

federally approved PSOs. 

Patient Safety Organization One, Inc. 

failed to respond to two findings of 

deficiency contained in a Notice of 

Proposed Revocation and Delisting: (1) 

Failure to provide required notification 

to AHRQ that the PSO has complied 

with the requirement of entering into 

two Patient Safety Act contracts within 

24-months of the date of initial listing, 

as required by 42 U.S.C. 299b– 

24(b)(1)(C); and (2) failure to submit 

information necessary for AHRQ to 

conduct a compliance assessment of the 

PSO, as required by 42 CFR 3.110. 

Patient Safety Organization One, Inc. 

has not responded to either preliminary 

notice of deficiency sent by AHRQ 

pursuant to 42 CFR 3.108(a)(2), nor 

provided any evidence of a good faith 

effort to correct either deficiency. 

Accordingly, pursuant to 42 CFR 

3.108(b), AHRQ delisted Patient Safety 

Organization One, Inc., PSO number 

P0059, effective at 12:00 Midnight ET 

(2400) on July 5, 2011. 


jlentini on DSK4TPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 184 / Thursday, September 22, 2011 / Notices 58813 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: September 8, 2011 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2011–24100 Filed 9–21–11; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–D–0271] 

Guidance for Industry; Measures to 

Address the Risk for Contamination by 

Salmonella Species in Food 

Containing a Pistachio-Derived 

Product as an Ingredient; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of a guidance entitled 

‘‘Guidance for Industry: Measures to 

Address the Risk for Contamination by 

Salmonella Species in Food Containing 

a Pistachio-Derived Product as an 

Ingredient.’’ The guidance clarifies for 

manufacturers who produce foods 

containing a pistachio-derived product 

as an ingredient that there is a risk that 

Salmonella species may be present in 

the incoming pistachio-derived product, 

and recommends measures to address 

that risk. 

DATES: Submit either electronic or 

written comments on Agency guidances 

at any time. 

ADDRESSES: Submit written requests for 

single copies of the guidance to the 

Division of Plant and Dairy Food Safety, 

Center for Food Safety and Applied 

Nutrition (HFS–317), Food and Drug 

Administration, 5100 Paint Branch 

Pkwy., College Park, MD 20740. Send 

two self-addressed adhesive labels to 

assist that office in processing your 

request. See the SUPPLEMENTARY

INFORMATION section for electronic 

access to the guidance. 

Submit electronic comments on the 

guidance to http://www.regulations.gov. 

Submit written comments on the 

guidance to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. 

FOR FURTHER INFORMATION CONTACT: 

Michael E. Kashtock, Center for Food 

Safety and Applied Nutrition (HFS– 

317), Food and Drug Administration, 

5100 Paint Branch Pkwy., College Park, 

MD 20740, 240–402–2022. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the Federal Register of June 29, 

2009 (74 FR 31038), FDA announced the 

availability of a draft guidance entitled 

‘‘Guidance for Industry: Measures to 

Address the Risk for Contamination by 

Salmonella Species in Food Containing 

a Pistachio-Derived Product as an 

Ingredient’’ and gave interested parties 

an opportunity to submit comments by 

August 28, 2009. The Agency reviewed 

and evaluated these comments and has 

modified the guidance where 

appropriate. 

The guidance clarifies for 

manufacturers who produce foods 

containing a pistachio-derived product 

as an ingredient that there is a risk that 

Salmonella species may be present in 

the incoming pistachio-derived product, 

and recommends measures to address 

that risk. Pistachio-derived products 

include roasted in-shell pistachios and 

shelled pistachios (also called kernels) 

that are roasted or raw. FDA is issuing 

this guidance as level 1 guidance 

consistent with FDA’s good guidance 

practices regulation (21 CFR 10.115). 

The guidance represents the Agency’s 

current thinking on measures to address 

the risk for contamination by 

Salmonella spp. in food containing a 

pistachio-derived product as an 

ingredient. It does not create or confer 

any rights for or on any person and does 

not operate to bind FDA or the public. 

An alternate approach may be used if 

such approach satisfies the 

requirements of the applicable statutes 

and regulations. 

II. Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) either electronic or written 

comments regarding the guidance. It is 

only necessary to send one set of 

comments. It is no longer necessary to 

send two copies of mailed comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

III. Electronic Access 

Persons with access to the Internet 

may obtain the guidance at http:// 

www.fda.gov/FoodGuidances or http:// 

www.regulations.gov. 

Dated: September 16, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–24317 Filed 9–21–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2011–0096] 

Homeland Security Advisory Council 

AGENCY: The Office of Policy, DHS. 

ACTION: Notice of open teleconference 

Federal Advisory Committee meeting. 

SUMMARY: The Homeland Security 

Advisory Council (HSAC) will meet via 

teleconference for the purpose of 

reviewing and deliberating on 

recommendations by the HSAC’s 

Southwest Border Task Force. 

DATES: The HSAC conference call will 

take place from 4 p.m. to 5 p.m. EDT on 

Monday, October 17, 2011. Please be 

advised that the meeting is scheduled 

for one hour and may end early if all 

business is completed before 5 p.m. 

ADDRESSES: The HSAC meeting will be 

held via teleconference. Members of the 

public interested in participating in this 

teleconference meeting may do so by 

following the process outlined below 

(see ‘‘Public Participation’’). Written 

comments must be submitted and 

received by October 14, 2011. 

Comments must be identified by Docket 

No. DHS–2011–0096 and may be 

submitted by one of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• E-mail: HSAC@dhs.gov. Include 

docket number in the subject line of the 

message. 

• Fax: (202) 282–9207 

• Mail: Homeland Security Advisory 

Council, Department of Homeland 

Security, Mailstop 0445, 245 Murray 

Lane, SW., Washington, DC 20528. 

Instructions: All submissions received 

must include the words ‘‘Department of 

Homeland Security’’ and DHS–2011– 

0096, the docket number for this action. 

Comments received will be posted 

without alteration at http:// 

www.regulations.gov, including any 

personal information provided. 

Docket: For access to the docket to 

read comments received by the DHS 

Homeland Security Advisory Council, 

go to http://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: Pat 

McQuillan at hsac@dhs.gov or 202–447– 

3135. 


jlentini on DSK4TPTVN1PROD with NOTICES